Civil Rights
Block on Trump's Asylum Ban Upheld by Supreme Court
Over the last 15 months, at least 103 patients have died after receiving heparin blood-thinning medication, according to information released Tuesday by the U.S. Food and Drug Administration. In February 2008, Baxter Healthcare Corporation recalled multi-dose and single-dose vials of heparin sodium for injection after FDA scientists identified a previously unknown contaminant in the heparin. To ensure that all is being done to provide a safe supply of heparin, FDA is urging medical device manufacturers to screen for the potentially harmful contaminant. The Los Angeles Times reports that "products to be tested cover a spectrum of equipment and uses," including "kits that flush out intravenous lines, drug-coated stents for opening clogged arteries and certain diagnostic tests that use heparin and could deliver inaccurate results if contaminated."
Sign into your Legal Forms and Services account to manage your estate planning documents.
Sign InCreate an account allows to take advantage of these benefits: